The Future of Cancer Treatment
For six years we have hosted The Future of Cancer Treatment (Fremtidens kreftbehandling) with the same partners. What is this seminar series all about?
Wenche Gerhardsen is Head of Communications at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator. You can reach her at wg@oslocancercluster.no
For six years we have hosted The Future of Cancer Treatment (Fremtidens kreftbehandling) with the same partners. What is this seminar series all about?
Dr. Bjørn Atle Bjørnbeth joined the board of Oslo Cancer Cluster during the annual general meeting.
We want to highlight the fruitful collaborations in the cluster. In a new article series, we present members who have a cluster story to tell. This week, we meet LINK Medical.
Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.